12 Result(s)

Article

Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis

CD19 CAR T-cell (CAR-T) therapy is commonly administered to patients with relapsed or refractory large B-cell lymphomas (LBCL), but salvage or bridging therapy can sometimes lead to a complete response (CR) pr...

Trent P. Wang, Kwang W. Ahn, Mazyar Shadman, Manmeet Kaur, Nausheen Ahmed… in Leukemia (2024)

Article

Endothelial activation and stress index as a prognostic factor of diffuse large B-cell lymphoma: the report from the nationwide multi-center Thai Lymphoma Study Group

Several prognostic models have been introduced to predict outcomes of patients with diffuse large B-cell lymphoma (DLBCL). Endothelial activation and stress index (EASIX) is a surrogate of endothelial dysfunct...

Ronakrit Thanhakun, Kitsada Wudhikarn, Udomsak Bunworasate… in Annals of Hematology (2023)

Article

Outcomes of polatuzumab vedotin-containing regimens in real-world setting of relapsed and or refractory diffuse large B-cell lymphoma patients: a matched-control analysis from the Thai Lymphoma Study Group (TLSG)

Relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) is a challenging condition to treat, and there is an unmet clinical need for effective therapies. Recently, polatuzumab vedotin (Pola), an anti-CD7...

Thanawat Rattanathammethee, Lalita Norasetthada… in Annals of Hematology (2023)

Chapter

Principles of Checkpoint Inhibition in Malignant Lymphoma

Malignancies manipulate the physiologic immune system through various immune checkpoint pathways to antagonize T cell activation and provide themselves an immune escape advantage. Targeting these inhibitory si...

Kitsada Wudhikarn, Stephen M. Ansell (2022)

Article

Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant

The graft-versus-leukemia (GVL) effect after allogeneic hematopoietic cell transplant (HCT) can prevent relapse but the risk of severe graft-versus-host disease (GVHD) leads to prolonged intensive immunosuppre...

Mina D. Aziz, Jay Shah, Urvi Kapoor, Christina Dimopoulos, Sarah Anand… in Leukemia (2020)

Article

Novel DDX41 variants in Thai patients with myeloid neoplasms

Germline DDX41 mutations were recently reported to cause MDS/AML and donor-derived leukemia after transplantation. While previously described in Western countries, DDX41 variants have not been reported in a South...

Chantana Polprasert, June Takeda, Pimjai Niparuck… in International Journal of Hematology (2020)

Article

Secondary central nervous system relapse in diffuse large B cell lymphoma in a resource limited country: result from the Thailand nationwide multi-institutional registry

Secondary central nervous system (CNS) relapse is a serious and fatal complication of diffuse large B cell lymphoma (DLBCL). Data on secondary CNS (SCNS) relapse were mostly obtained from western countries wit...

Kitsada Wudhikarn, Udomsak Bunworasate, Jakrawadee Julamanee… in Annals of Hematology (2017)

Article

Daptomycin nonsusceptible enterococci in hematologic malignancy and hematopoietic stem cell transplant patients: an emerging threat

Kitsada Wudhikarn, Roger D. Gingrich… in Annals of Hematology (2013)